<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Gastrointestinal System</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Gastrointestinal System</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                34 Questions | 136 Total Marks | 44 min Duration | ~77.65 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 34 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 44 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 34</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Gastrointestinal System - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 34</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 34 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Mechanism of action of an aprepitant is?", "options": [{"label": "A", "text": "RANK ligand inhibitor", "correct": false}, {"label": "B", "text": "NMDA antagonist", "correct": false}, {"label": "C", "text": "NK 1 receptor antagonist", "correct": true}, {"label": "D", "text": "5 HT3 antagonist", "correct": false}], "correct_answer": "C. NK 1 receptor antagonist", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) NK 1 receptor antagonist</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. RANK ligand inhibitor: Incorrect because RANK ligand inhibitors like denosumab are used to treat osteoporosis and bone metastases , not nausea and vomiting. These drugs inhibit RANK ligand, a protein essential for the formation and survival of osteoclasts, which are involved in bone resorption.</li><li>â€¢ Option A. RANK ligand inhibitor:</li><li>â€¢ Incorrect</li><li>â€¢ RANK ligand inhibitors</li><li>â€¢ denosumab</li><li>â€¢ treat osteoporosis</li><li>â€¢ bone</li><li>â€¢ metastases</li><li>â€¢ inhibit RANK ligand,</li><li>â€¢ formation and survival of</li><li>â€¢ osteoclasts,</li><li>â€¢ bone resorption.</li><li>â€¢ Option B. NMDA antagonist: Incorrect as NMDA antagonists, such as memantine , target cognitive decline in Alzheimerâ€™s disease rather than nausea and vomiting.</li><li>â€¢ Option B. NMDA antagonist:</li><li>â€¢ Incorrect</li><li>â€¢ NMDA antagonists,</li><li>â€¢ memantine</li><li>â€¢ target cognitive</li><li>â€¢ Alzheimerâ€™s disease</li><li>â€¢ nausea and vomiting.</li><li>â€¢ Option D. 5 HT3 antagonist: Incorrect because 5-HT3 antagonists, like ondansetron and granisetron , also prevent nausea and vomiting in settings like chemotherapy and post-operation but function by blocking 5-HT3 receptors on the vagus nerve and in the central nervous system , not NK1 receptors.</li><li>â€¢ Option D. 5 HT3 antagonist:</li><li>â€¢ Incorrect</li><li>â€¢ 5-HT3 antagonists,</li><li>â€¢ ondansetron and granisetron</li><li>â€¢ prevent nausea and</li><li>â€¢ vomiting</li><li>â€¢ chemotherapy and post-operation</li><li>â€¢ blocking 5-HT3 receptors</li><li>â€¢ vagus nerve</li><li>â€¢ central nervous system</li><li>â€¢ not NK1 receptors.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ NK1 receptor antagonist used primarily to prevent delayed chemotherapy-induced nausea and vomiting by inhibiting the action of substance P on NK1 receptors.</li><li>âž¤ NK1 receptor antagonist</li><li>âž¤ prevent delayed chemotherapy-induced nausea and vomiting</li><li>âž¤ inhibiting</li><li>âž¤ substance P on NK1 receptors.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Despite their short half-lives (2 hrs), proton pump inhibitors (PPIs) cause a prolonged suppression of acid secretion (up to 48 hrs) because?", "options": [{"label": "A", "text": "They are pro-drugs and undergo activation gradually", "correct": false}, {"label": "B", "text": "From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time", "correct": false}, {"label": "C", "text": "They irreversible inhibit the proton pump molecule", "correct": true}, {"label": "D", "text": "They are available as enteric coated capsules, from which drug is gradually released", "correct": false}], "correct_answer": "C. They irreversible inhibit the proton pump molecule", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) They irreversible inhibit the proton pump molecule</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. They are pro-drugs and undergo activation gradually: Incorrect because while PPIs are indeed prodrugs that are activated within the acidic environment of the parietal cells , the gradual activation does not directly contribute to the prolonged acid suppression . The prolongation comes from the irreversible inhibition of the pumps.</li><li>â€¢ Option A. They are pro-drugs and undergo activation gradually:</li><li>â€¢ Incorrect</li><li>â€¢ PPIs</li><li>â€¢ prodrugs</li><li>â€¢ within</li><li>â€¢ parietal cells</li><li>â€¢ gradual activation does not</li><li>â€¢ prolonged acid</li><li>â€¢ suppression</li><li>â€¢ irreversible inhibition of the pumps.</li><li>â€¢ Option B. From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time: Incorrect because PPIs do not travel directly from the stomach to the parietal cells. They must first be absorbed from the intestine and then distributed to the parietal cells via the bloodstream.</li><li>â€¢ Option B. From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time:</li><li>â€¢ Incorrect</li><li>â€¢ PPIs do not</li><li>â€¢ stomach to the parietal cells.</li><li>â€¢ absorbed from the intestine</li><li>â€¢ distributed to the parietal cells</li><li>â€¢ bloodstream.</li><li>â€¢ Option D. They are available as enteric coated capsules, from which drug is gradually released: Incorrect as the enteric coating only serves to protect the drug from gastric acid degradation rather than prolonging its action at the site of the proton pumps.</li><li>â€¢ Option D. They are available as enteric coated capsules, from which drug is gradually released:</li><li>â€¢ Incorrect</li><li>â€¢ enteric coating</li><li>â€¢ protect the drug</li><li>â€¢ gastric acid degradation</li><li>â€¢ prolonging its action</li><li>â€¢ site of the proton pumps.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Proton pump inhibitor s cause prolonged acid suppression by irreversibly binding to and inactivating the proton pumps in the stomach, and acid secretion only resumes once new pumps are synthesized and active.</li><li>âž¤ Proton pump inhibitor</li><li>âž¤ prolonged acid suppression</li><li>âž¤ irreversibly binding to</li><li>âž¤ inactivating the proton pumps</li><li>âž¤ acid secretion</li><li>âž¤ resumes</li><li>âž¤ new pumps are synthesized and active.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient of peptic ulcer was prescribed ranitidine and sucralfate in the morning hours. Why is this combination incorrect?", "options": [{"label": "A", "text": "Ranitidine combines with sucralfate and prevents its action", "correct": false}, {"label": "B", "text": "Combination of these two drugs produces serious side effects like agranulocytosis", "correct": false}, {"label": "C", "text": "Ranitidine increases the gastric pH so sucralfate is not able to act", "correct": true}, {"label": "D", "text": "Sucralfate inhibits the absorption of ranitidine", "correct": false}], "correct_answer": "C. Ranitidine increases the gastric pH so sucralfate is not able to act", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Ranitidine increases the gastric pH so sucralfate is not able to act</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Ranitidine combines with sucralfate and prevents its action: Incorrect because ranitidine does not chemically combine with sucralfate ; the issue is the pH environment alteration.</li><li>â€¢ Option A. Ranitidine combines with sucralfate and prevents its action:</li><li>â€¢ Incorrect</li><li>â€¢ ranitidine does not</li><li>â€¢ sucralfate</li><li>â€¢ pH environment alteration.</li><li>â€¢ Option B. Combination of these two drugs produces serious side effects like agranulocytosis: Incorrect as there is no evidence to suggest that agranulocytosis is a common side effect of combining these two drugs.</li><li>â€¢ Option B. Combination of these two drugs produces serious side effects like agranulocytosis:</li><li>â€¢ no</li><li>â€¢ agranulocytosis</li><li>â€¢ common side effect</li><li>â€¢ two drugs.</li><li>â€¢ Option D. Sucralfate inhibits the absorption of ranitidine: Incorrect because sucralfate does not affect the absorption of ranitidine; its primary interaction is with the gastric pH affecting its own mechanism of action.</li><li>â€¢ Option D. Sucralfate inhibits the absorption of ranitidine:</li><li>â€¢ Incorrect</li><li>â€¢ sucralfate does not</li><li>â€¢ absorption of ranitidine;</li><li>â€¢ gastric pH</li><li>â€¢ own mechanism of action.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Sucralfate needs an acidic environment to be effective. Co-administration with ranitidine, which raises gastric pH, can impair the effectiveness of sucralfate in treating ulcers.</li><li>âž¤ Sucralfate</li><li>âž¤ acidic environment</li><li>âž¤ effective.</li><li>âž¤ Co-administration</li><li>âž¤ ranitidine,</li><li>âž¤ raises gastric pH,</li><li>âž¤ impair</li><li>âž¤ effectiveness of sucralfate</li><li>âž¤ ulcers.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following adverse effects are associated with the use of proton pump inhibitors except?", "options": [{"label": "A", "text": "Community acquired pneumonia", "correct": false}, {"label": "B", "text": "Clostridium difficile infection", "correct": false}, {"label": "C", "text": "Osteoporosis", "correct": false}, {"label": "D", "text": "Hypothyroidism", "correct": true}], "correct_answer": "D. Hypothyroidism", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Hypothyroidism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Community acquired pneumonia: Correctly associated with PPIs. Some studies have indicated an increased risk of pneumonia, particularly in vulnerable groups such as the elderly or those with existing respiratory conditions , possibly due to alterations in stomach pH affecting gut and respiratory flora.</li><li>â€¢ Option A. Community acquired pneumonia:</li><li>â€¢ PPIs.</li><li>â€¢ increased risk of</li><li>â€¢ pneumonia,</li><li>â€¢ elderly</li><li>â€¢ existing respiratory conditions</li><li>â€¢ alterations in stomach pH</li><li>â€¢ gut and respiratory flora.</li><li>â€¢ Option B. Clostridium difficile infection: Correctly associated with PPIs. The reduction in gastric acidity can lead to an environment more conducive to the growth of Clostridium difficile , potentially resulting in severe and life-threatening infections.</li><li>â€¢ Option B. Clostridium difficile infection:</li><li>â€¢ Correctly</li><li>â€¢ PPIs.</li><li>â€¢ reduction in gastric acidity</li><li>â€¢ more conducive</li><li>â€¢ growth of Clostridium difficile</li><li>â€¢ severe and life-threatening infections.</li><li>â€¢ Option C. Osteoporosis: Correctly associated with PPIs . Chronic use of PPIs may impact calcium absorption and bone metabolism, leading to an increased risk of osteoporosis and related fractures, especially in populations at risk like postmenopausal women and the elderly.</li><li>â€¢ Option C. Osteoporosis:</li><li>â€¢ Correctly</li><li>â€¢ PPIs</li><li>â€¢ Chronic</li><li>â€¢ PPIs</li><li>â€¢ impact calcium absorption</li><li>â€¢ bone metabolism,</li><li>â€¢ increased risk of osteoporosis</li><li>â€¢ fractures,</li><li>â€¢ risk like postmenopausal women</li><li>â€¢ elderly.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ While PPIs are linked to several significant adverse effects such as increased risks of community-acquired pneumonia, Clostridium difficile infections , and osteoporosis , they are not associated with causing or worsening hypothyroidism.</li><li>âž¤ PPIs are linked</li><li>âž¤ adverse effects</li><li>âž¤ increased risks of community-acquired pneumonia,</li><li>âž¤ Clostridium</li><li>âž¤ difficile infections</li><li>âž¤ osteoporosis</li><li>âž¤ not</li><li>âž¤ causing or worsening hypothyroidism.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following drugs have least affinity for CYP3A4?", "options": [{"label": "A", "text": "Omeprazole", "correct": false}, {"label": "B", "text": "Lansoprazole", "correct": false}, {"label": "C", "text": "Esomeprazole", "correct": false}, {"label": "D", "text": "Rabeprazole", "correct": true}], "correct_answer": "D. Rabeprazole", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Rabeprazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Omeprazole: Incorrect because Omeprazole is extensively metabolized by CYP3A4, making it more likely to interact with other drugs metabolized by this enzyme.</li><li>â€¢ Option A. Omeprazole:</li><li>â€¢ Incorrect</li><li>â€¢ Omeprazole</li><li>â€¢ extensively metabolized by CYP3A4,</li><li>â€¢ more likely</li><li>â€¢ interact</li><li>â€¢ other drugs</li><li>â€¢ Option B. Lansoprazole: Incorrect as Lansoprazole also has significant metabolism via CYP3A4, similar to omeprazole, which increases its potential for drug interactions.</li><li>â€¢ Option B. Lansoprazole:</li><li>â€¢ Incorrect</li><li>â€¢ Lansoprazole</li><li>â€¢ CYP3A4,</li><li>â€¢ omeprazole,</li><li>â€¢ increases its potential</li><li>â€¢ drug interactions.</li><li>â€¢ Option C. Esomeprazole: Incorrect because Esomeprazole, the S-isomer of omeprazole, is extensively metabolized by CYP3A4 , thus having a higher affinity for this enzyme compared to rabeprazole.</li><li>â€¢ Option C. Esomeprazole:</li><li>â€¢ Incorrect</li><li>â€¢ Esomeprazole,</li><li>â€¢ S-isomer of omeprazole,</li><li>â€¢ metabolized by CYP3A4</li><li>â€¢ higher affinity for this enzyme</li><li>â€¢ rabeprazole.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Rabeprazole has the least affinity for the enzyme CYP3A4 among the listed PPIs , potentially leading to fewer drug interactions related to metabolism by this pathway.</li><li>âž¤ Rabeprazole</li><li>âž¤ least affinity</li><li>âž¤ CYP3A4</li><li>âž¤ listed PPIs</li><li>âž¤ fewer drug interactions</li><li>âž¤ metabolism</li><li>âž¤ this pathway.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30-year-old pregnant woman has a history of rheumatoid arthritis which has been managed successfully with NSAIDs. However, she has recently visited her general practitioner complaining of burning epigastric pain worsened by food intake. Which of the following ulcer medication is most likely contraindicated in this patient?", "options": [{"label": "A", "text": "Famotidine", "correct": false}, {"label": "B", "text": "Omeprazole", "correct": false}, {"label": "C", "text": "Misoprostol", "correct": true}, {"label": "D", "text": "Ranitidine", "correct": false}], "correct_answer": "C. Misoprostol", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Misoprostol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Famotidine: Incorrect as Famotidine, an H2 receptor antagonist, is generally considered safe for use during pregnancy . It works by reducing stomach acid and is not known to harm the fetus.</li><li>â€¢ Option A. Famotidine:</li><li>â€¢ Incorrect</li><li>â€¢ H2 receptor antagonist,</li><li>â€¢ considered safe</li><li>â€¢ during pregnancy</li><li>â€¢ reducing stomach acid</li><li>â€¢ not</li><li>â€¢ harm the fetus.</li><li>â€¢ Option B. Omeprazole: Incorrect because Omeprazole , a proton pump inhibitor , is also used to manage ulcer symptoms by reducing acid production. While its use in pregnancy should be cautious, it is not specifically contraindicated like Misoprostol.</li><li>â€¢ Option B. Omeprazole:</li><li>â€¢ Incorrect</li><li>â€¢ Omeprazole</li><li>â€¢ proton pump inhibitor</li><li>â€¢ used</li><li>â€¢ reducing</li><li>â€¢ acid production.</li><li>â€¢ use in pregnancy</li><li>â€¢ cautious,</li><li>â€¢ not</li><li>â€¢ contraindicated</li><li>â€¢ Misoprostol.</li><li>â€¢ Option D. Ranitidine: Incorrect as Ranitidine, another H2 receptor antagonist, is typically safe for use during pregnancy. It works similarly to Famotidine by reducing gastric acid and is not associated with significant risks to the developing fetus.</li><li>â€¢ Option D. Ranitidine:</li><li>â€¢ Incorrect</li><li>â€¢ H2 receptor antagonist,</li><li>â€¢ safe</li><li>â€¢ during pregnancy.</li><li>â€¢ similarly to Famotidine</li><li>â€¢ reducing gastric acid</li><li>â€¢ not</li><li>â€¢ risks</li><li>â€¢ developing fetus.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Misoprostol is contraindicated in pregnant patients due to its potential to induce uterine contractions and risk causing abortion.</li><li>âž¤ Misoprostol</li><li>âž¤ contraindicated in pregnant</li><li>âž¤ its potential</li><li>âž¤ induce uterine contractions</li><li>âž¤ risk</li><li>âž¤ abortion.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Drug implicated in prolonging QT interval is?", "options": [{"label": "A", "text": "Domperidone", "correct": false}, {"label": "B", "text": "Metoclopramide", "correct": false}, {"label": "C", "text": "Cisapride", "correct": true}, {"label": "D", "text": "Omeprazole", "correct": false}], "correct_answer": "C. Cisapride", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-095836.png"], "explanation": "<p><strong>Ans. C) Cisapride</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Domperidone: Incorrect because while Domperidone does have some cardiac risk , it is more specifically associated with an increased risk of serious ventricular arrhythmias and sudden cardiac death rather than QT prolongation.</li><li>â€¢ Option A. Domperidone:</li><li>â€¢ Incorrect</li><li>â€¢ Domperidone</li><li>â€¢ cardiac risk</li><li>â€¢ increased risk of serious ventricular arrhythmias</li><li>â€¢ sudden cardiac death</li><li>â€¢ Option B. Metoclopramide: Incorrect as Metoclopramide, another prokinetic agent, primarily affects dopamine receptors and has not been commonly associated with QT prolongation.</li><li>â€¢ Option B. Metoclopramide:</li><li>â€¢ Incorrect</li><li>â€¢ prokinetic agent,</li><li>â€¢ dopamine receptors</li><li>â€¢ not</li><li>â€¢ QT prolongation.</li><li>â€¢ Option D. Omeprazole: Incorrect because Omeprazole, a proton pump inhibitor, does not typically cause QT prolongation as part of its side effect profile.</li><li>â€¢ Option D. Omeprazole:</li><li>â€¢ Incorrect</li><li>â€¢ proton pump inhibitor,</li><li>â€¢ does not</li><li>â€¢ QT prolongation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Cisapride is associated with QT interval prolongation and can lead to torsades de pointes , particularly at high concentrations or when combined with other drugs that inhibit its metabolism.</li><li>âž¤ Cisapride</li><li>âž¤ QT interval prolongation</li><li>âž¤ torsades de pointes</li><li>âž¤ high concentrations</li><li>âž¤ combined with other drugs</li><li>âž¤ inhibit its metabolism.</li><li>âž¤ Important drugs causing QT prolongation</li><li>âž¤ Important drugs causing QT prolongation</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All the following statements about treatment of diarrhea are correct except?", "options": [{"label": "A", "text": "Opioids delay passage of gut contents by reducing peristalsis", "correct": false}, {"label": "B", "text": "Loperamide is an opioid with anti-motility action", "correct": false}, {"label": "C", "text": "Anti-motility drugs are best drugs for infective diarrhea", "correct": true}, {"label": "D", "text": "Diphenoxylate overdose can cause respiratory depression", "correct": false}], "correct_answer": "C. Anti-motility drugs are best drugs for infective diarrhea", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Anti-motility drugs are best drugs for infective diarrhea</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Opioids delay passage of gut contents by reducing peristalsis: Correct , opioids inhibit gastrointestinal motility, leading to slower transit times and more water absorption , which can help alleviate diarrhea symptoms.</li><li>â€¢ Option A. Opioids delay passage of gut contents by reducing peristalsis:</li><li>â€¢ Correct</li><li>â€¢ inhibit gastrointestinal motility,</li><li>â€¢ slower transit</li><li>â€¢ more water absorption</li><li>â€¢ alleviate diarrhea symptoms.</li><li>â€¢ Option B. Loperamide is an opioid with anti-motility action: Correct , loperamide acts on opioid receptors in the gastrointestinal tract to reduce motility and increase the absorption of fluids, making it effective in managing diarrhea.</li><li>â€¢ Option B. Loperamide is an opioid with anti-motility action:</li><li>â€¢ Correct</li><li>â€¢ loperamide</li><li>â€¢ opioid receptors</li><li>â€¢ gastrointestinal</li><li>â€¢ tract</li><li>â€¢ reduce motility</li><li>â€¢ increase the absorption of fluids,</li><li>â€¢ Option D. Diphenoxylate overdose can cause respiratory depression: Correct, diphenoxylate is an opioid and, like other opioids, can cause significant respiratory depression if overdosed.</li><li>â€¢ Option D. Diphenoxylate overdose can cause respiratory depression:</li><li>â€¢ Correct,</li><li>â€¢ diphenoxylate</li><li>â€¢ opioid</li><li>â€¢ respiratory depression</li><li>â€¢ overdosed.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ While anti-motility drugs are effective in managing non-infective diarrhea, they are not recommended for treating infective diarrhea due to the risk of prolonging the presence of pathogens in the gastrointestinal tract.</li><li>âž¤ anti-motility drugs</li><li>âž¤ effective</li><li>âž¤ non-infective diarrhea,</li><li>âž¤ not</li><li>âž¤ treating infective diarrhea</li><li>âž¤ risk</li><li>âž¤ presence of pathogens</li><li>âž¤ gastrointestinal tract.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "False statement about racecadotril is?", "options": [{"label": "A", "text": "It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor", "correct": false}, {"label": "B", "text": "It is a drug used in treatment of constipation", "correct": true}, {"label": "C", "text": "It is metabolized by liver", "correct": false}, {"label": "D", "text": "It has anti- secretory action in GIT", "correct": false}], "correct_answer": "B. It is a drug used in treatment of constipation", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) It is drug used in constipation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor: Correct , racecadotril is a pro-drug that is metabolized into thiorphan , which acts peripherally to inhibit enkephalinase , thus prolonging the action of naturally occurring opioids that decrease gut motility.</li><li>â€¢ Option A. It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor:</li><li>â€¢ Correct</li><li>â€¢ racecadotril</li><li>â€¢ pro-drug</li><li>â€¢ metabolized into thiorphan</li><li>â€¢ peripherally</li><li>â€¢ inhibit enkephalinase</li><li>â€¢ prolonging the action</li><li>â€¢ naturally occurring</li><li>â€¢ opioids</li><li>â€¢ decrease gut motility.</li><li>â€¢ Option C. It is metabolized by liver: Correct, racecadotril undergoes metabolic processes in the liver, converting it into its active form.</li><li>â€¢ Option C. It is metabolized by liver:</li><li>â€¢ Correct, racecadotril</li><li>â€¢ metabolic</li><li>â€¢ liver,</li><li>â€¢ its active</li><li>â€¢ form.</li><li>â€¢ Option D. It has anti-secretory action in GIT: Correct, by inhibiting the breakdown of enkephalins, racecadotril enhances their natural anti-secretory effects in the gastrointestinal tract, which is beneficial in treating diarrhea.</li><li>â€¢ Option D. It has anti-secretory action in GIT:</li><li>â€¢ Correct,</li><li>â€¢ inhibiting the breakdown of enkephalins,</li><li>â€¢ racecadotril</li><li>â€¢ natural</li><li>â€¢ anti-secretory effects in the gastrointestinal tract,</li><li>â€¢ beneficial</li><li>â€¢ treating diarrhea.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Racecadotril is indicated for the treatment of acute diarrhea and works by reducing gastrointestinal secretion; it is not used for constipation and indeed would be contraindicated in such cases.</li><li>âž¤ Racecadotril</li><li>âž¤ indicated</li><li>âž¤ acute diarrhea</li><li>âž¤ reducing gastrointestinal secretion;</li><li>âž¤ not</li><li>âž¤ constipation</li><li>âž¤ indeed</li><li>âž¤ contraindicated</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Racecadotril is used for?", "options": [{"label": "A", "text": "Chronic diarrhea", "correct": false}, {"label": "B", "text": "Acute secretory diarrhea", "correct": true}, {"label": "C", "text": "Chronic constipation", "correct": false}, {"label": "D", "text": "Diabetic gastroparesis", "correct": false}], "correct_answer": "B. Acute secretory diarrhea", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Acute secretory diarrhea</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Chronic diarrhea: Incorrect because Racecadotril is not used for chronic diarrhea conditions as its effects are more suited to acute cases.</li><li>â€¢ Option A. Chronic diarrhea:</li><li>â€¢ Incorrect</li><li>â€¢ Racecadotril</li><li>â€¢ not</li><li>â€¢ chronic diarrhea</li><li>â€¢ acute cases.</li><li>â€¢ Option C. Chronic constipation: Incorrect as Racecadotril